Structure Therapeutics (GPCR) Retained Earnings (2022 - 2026)

Structure Therapeutics' Retained Earnings history runs 5 years deep, the most recent figure standing at -$546.3 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 145.53% year-over-year to -$546.3 million; the TTM figure through Mar 2026 stood at -$546.3 million (down 145.53% YoY), while the FY2025 annual figure was -$470.3 million, down 51555.14% from the prior year.
• Retained Earnings for Q1 2026 stood at -$546.3 million, down from -$470.3 million in the prior quarter.
• The five-year high for Retained Earnings was $1.3 billion in Q3 2025, with the low at -$546.3 million in Q1 2026.
• The 5-year median for Retained Earnings is -$146.6 million (2023), against an average of $139.2 million.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings jumped 663.48% in 2023, then plunged 51555.14% in 2025.
• Structure Therapeutics' Retained Earnings stood at -$117.0 million in 2022, then surged by 663.48% to $659.0 million in 2023, then plunged by 99.86% to $914000.0 in 2024, then slumped by 51555.14% to -$470.3 million in 2025, then retreated by 16.16% to -$546.3 million in 2026.
• Business Quant data shows GPCR's Retained Earnings at -$546.3 million in Q1 2026, -$470.3 million in Q4 2025, and $1.3 billion in Q3 2025.